MACLEODS PHARMS LTD FDA Approval ANDA 203147

ANDA 203147

MACLEODS PHARMS LTD

FDA Drug Application

Application #203147

Application Sponsors

ANDA 203147MACLEODS PHARMS LTD

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORALEQ 5MG BASE0RIZATRIPTAN BENZOATERIZATRIPTAN BENZOATE
002TABLET;ORALEQ 10MG BASE0RIZATRIPTAN BENZOATERIZATRIPTAN BENZOATE

FDA Submissions

UNKNOWN; ORIG1AP2014-02-11
LABELING; LabelingSUPPL15AP2019-11-29STANDARD

Submissions Property Types

ORIG1Null15
SUPPL15Null7

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

MACLEODS PHARMS LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 203147
            [companyName] => MACLEODS PHARMS LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"RIZATRIPTAN BENZOATE","activeIngredients":"RIZATRIPTAN BENZOATE","strength":"EQ 5MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"RIZATRIPTAN BENZOATE","activeIngredients":"RIZATRIPTAN BENZOATE","strength":"EQ 10MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"02\/11\/2014","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"11\/29\/2019","submission":"SUPPL-15","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2019-11-29
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.